Skip to main content
. 2014 Aug 29;9(8):e105268. doi: 10.1371/journal.pone.0105268

Table 4. Predictive factors of survival after bone metastases diagnosis.

VARIABLES MEDIAN TIME(MONTHS) p VALUE(uni variate) p VALUE(multivariate) HAZARDRATIO (HR)
Age 0.349
<70 Years 7.0 (5.83–8.18)
>70 Years 6.0 (4.35–7.65)
Gender 0.612
Male 6.0 (5.07–6.93)
Female 9.0 (7.33–10.67)
Aetiology 0.003 0.005 0.785
HBV-related 4.0 (2.18–5.82)
HCV-related 7.0 (5.61–8.39)
Alcohol-related cirrhosis 9.0 (4.73–13.27)
Other 8.0 (5.10–10.90)
Grading 0.866
G1 5.0 (3.38–6.62)
G2 6.0 (3.74–8.26)
G3 6.0 (4.04–7.96)
Locoregional Treatment 0.104
No 6.0 (4.93–7.07)
Yes 7.0 (5.97–8.03)
Type of locoregional Treatment 0.644
Surgery 8.0 (6.23–9.77)
Interventional Radiology 7.0 (5.72–8.28)
Type of interventional Radiology 0.366
RFA 7.0 (4.76–9.24)
TACE 7.0 (5.25–8.76)
PEI 7.0 (0.00–19.47)
CHILD Score (at time of Bone Metastasis) 0.245
A 6.0 (4.95–7.06)
B 6.0 (3.93–8.07)
C 9.0 (5.08–12.92)
AFP (at diagnosis) 0.549
<43 ng\ml 7.0 (5.22–8.78)
>43 ng/ml 7.0 (5.93–8.07)
Visceral Metastasis 0.615
Yes 7.0 (4.14–9.86)
No 7.0 (6.03–7.97)
ECOG PS (at time of Bone Metastasis) 0.002 0.002 1.341
0 8.0 (5.28–10.72)
1 8.0 (6.75–9.25)
2 6.0 (4.85–7.15)
3 4.0 (0.33–7.67)
Bone Lesion Type 0.608
Osteolytic 7.0 (6.05–7.95)
Ostroblastic 9.0 (7.70–10.30)
Mixed 7.0 (4.16–9.84)
Bone metastasis - Spine 0.006 0.075 1.339
No 9.0 (7.34–10.66)
Yes 6.0 (5.05–6.95)
Bone Metastasis - Long Bones 0.806
No 7.0 (6.11–7.89)
Yes 6.0 (2.48–9.52)
Bone Metastasis - Hip 0.428
No 7.0 (5.95–8.05)
Yes 6.0 (3.65–8.35)
Bone Metastasis - Other 0.941
No 7.0 (5.86–8.14)
Yes 7.0 (5.60–8.40)
First SRE Type 0.268
Pathologica Fracture 7.0 (3.90–10.10)
Hypercalcemia 9.0 (7.83–10–17)
Spinal Cord Compression 4.0 (0.00–9.09)
Surgery to Bone 9.0 (7.83–10.17)
Radiation to Bone 8.0 (6.55–9.45)
Biphosphonate Treatment 0.001 0.024 0.699
No 5.0 (3.58–6.42)
Yes 8.0 (6.78–9.23)